Teleflex (TFX) Stock Forecast & Price Target
$5.92B
Market Cap
-5.97
P/E
19.37
Forward P/E
43
Score
TFX price $139.82 +0.84 +0.61%
Stocklytics score rationale: value 58, quality 50, growth 20.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1868027000 | 2146303000 | 2448383000 | 2595362000 | 2537156000 | 2809563000 | 2791041000 | 2974489000 | 3047324000 | 1992713000 |
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include…
Consensus Buy from 13 analysts. Average price target $154.25, +10.3% versus the current price. Low $140.00. High $170.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $154.25 for Teleflex (TFX), 9.5% above the current price of $140.92. Of 13 analysts covering the stock, 6 rate it Buy or Strong Buy, 7 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $140.00 |
|---|---|
| Average | $154.25 |
| High | $170.00 |
The average is 9.5% above the current price of $140.92.
Of 13 analysts, 6 rate Teleflex Buy or Strong Buy, 7 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS $7.22, revenue $2.27 billion. 2027, EPS $10.95, revenue $2.37 billion.
The Stocklytics Score for TFX is 43 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$154.25 average, with a published range of $140.00 to $170.00.
The consensus is Buy from 13 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $7.22. The average revenue estimate is $2.27 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Teleflex · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$5.92B
Market Cap
-5.97
P/E
19.37
Forward P/E
43
Score